Results 151 to 160 of about 149,549 (197)

Intralesional Vitamin D3 for Anogenital Warts in Human Immunodeficiency Virus Infected Individual. [PDF]

Int Med Case Rep J
Zulfan, Amalia SN, Maharani RH, Rowawi R, Achdiat PA.   +4 more
europepmc   +1 more source

Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib. [PDF]

An Bras Dermatol
Moreira Gomes P, Costa R, Pedrosa A, Lisboa C.   +3 more
europepmc   +1 more source

Classic Kaposi Sarcoma: Current Treatment Strategies and Emerging Therapeutic Approaches. [PDF]

Cancers (Basel)
Revenko D, Shirron N, Shainer R, Avitan-Hersh E, Zer A.   +4 more
europepmc   +1 more source

EADO classification of difficult-to-treat cutaneous squamous cell carcinoma in transplant recipients. [PDF]

J Eur Acad Dermatol Venereol
Lara-Trigo J, Gómez-Tomás Á, Estany-Bécares A, Ruiz-Álvarez De Arcaya I, Casamitjana-Casabó A, Ferrándiz-Pulido C.   +5 more
europepmc   +1 more source

Plantar Myrmecia Wart: A Rare Case Report With Clinicopathologic Correlation and Literature Review. [PDF]

Cureus
Patel T, Singh G, Thesiya Y, Singh Pathania Y.   +3 more
europepmc   +1 more source

Resolution of Recalcitrant Extensive Verruca Plana with Pulsed-Dye Laser. [PDF]

Indian Dermatol Online J
Najeeb A, Ahuja R, Khandpur S, Bhari N.
europepmc   +1 more source

Intralesional immunotherapy for pediatric warts: A review [PDF]

Pediatric Dermatology, 2020
AbstractCutaneous warts are a common pediatric complaint with modest response to first‐line treatments. Warts are a manifestation of human papillomavirus (HPV) infection and are cleared by cell‐mediated immunity (CMI). Intralesional immunotherapy treatments have been studied as alternative therapies, particularly for recalcitrant or multiple warts ...
Jennifer Schoch, Sami Saikaly
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Intralesional immunotherapy for molluscum contagiosum: A review

Dermatologic Therapy, 2020
Molluscum contagiosum (MC) is a common cutaneous viral infection with no standard treatment. The virus responsible for MC is thought to be cleared by cell mediated immunity (CMI). Intralesional immunotherapy that stimulates CMI has been shown to be an effective treatment for other cutaneous viruses.
Jennifer Schoch, Sami Saikaly
exaly   +3 more sources

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

Cancers, 2021
Direct intralesional injection of specific or even generic agents, has been proposed over the years as cancer immunotherapy, in order to treat cutaneous or subcutaneous metastasis.
Pier Francesco Ferrucci, Laura Pala, Fabio Conforti   +2 more
exaly   +2 more sources